Cargando…

Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome

Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaalouk, Tamer Mohamed, Bitar, Zouheir Ibrahim, Maadarani, Ossama Sajeh, Elhabibi, Mohamed Elsayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813119/
https://www.ncbi.nlm.nih.gov/pubmed/33505688
http://dx.doi.org/10.1002/ccr3.3509
_version_ 1783637795644899328
author Zaalouk, Tamer Mohamed
Bitar, Zouheir Ibrahim
Maadarani, Ossama Sajeh
Elhabibi, Mohamed Elsayed
author_facet Zaalouk, Tamer Mohamed
Bitar, Zouheir Ibrahim
Maadarani, Ossama Sajeh
Elhabibi, Mohamed Elsayed
author_sort Zaalouk, Tamer Mohamed
collection PubMed
description Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome.
format Online
Article
Text
id pubmed-7813119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78131192021-01-26 Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome Zaalouk, Tamer Mohamed Bitar, Zouheir Ibrahim Maadarani, Ossama Sajeh Elhabibi, Mohamed Elsayed Clin Case Rep Case Reports Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome. John Wiley and Sons Inc. 2020-11-11 /pmc/articles/PMC7813119/ /pubmed/33505688 http://dx.doi.org/10.1002/ccr3.3509 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Zaalouk, Tamer Mohamed
Bitar, Zouheir Ibrahim
Maadarani, Ossama Sajeh
Elhabibi, Mohamed Elsayed
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_full Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_fullStr Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_full_unstemmed Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_short Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_sort carbamazepine‐induced stevens‐johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813119/
https://www.ncbi.nlm.nih.gov/pubmed/33505688
http://dx.doi.org/10.1002/ccr3.3509
work_keys_str_mv AT zaalouktamermohamed carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome
AT bitarzouheiribrahim carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome
AT maadaraniossamasajeh carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome
AT elhabibimohamedelsayed carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome